// App-Quantinova.ai

GW26-e5383 : Pioglitazone Decreases Plaque Thrombosis by Attenuating Plaque Inflammation. An In Vivo Study Using 18F-FDG PET/CT

Researchers

Presenter

  • Quanming Zhao

Principal Investigators

  • Mingduo Zhang

  • Xin Zhao

  • Tingting Feng

Medical Centers

  • Beijing Anzhen Hospital, Capital Medical University, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary Artery Disease

  • Venous thrombosis

Biomarkers

  • 18F-fluorodeoxyglucose

  • High sensitivity C-reactive protein

  • Matrix metallopeptidase 9

Drug/Treatment

  • Insulin sensitizer

  • Pioglitazone

  • Actoplus Met XR extended-release tablet

  • Fludeoxyglucose (18F)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved